MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells-Reference-Cited by-同舟云学术

MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells

Published:2006-12 Issue:1 Volume:351 Page:192-197
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Kang Jung-Hee,Rychahou Piotr G.,Ishola Titilope A.,Qiao Jingbo,Evers B. Mark,Chung Dai H.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference26 articles.

1. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee;Shimada;Cancer,1999

2. Targeted expression of MYCN causes neuroblastoma in transgenic mice;Weiss;EMBO J.,1997

3. Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line;Negroni;Cell Growth Differ.,1991

4. Episome-generated N-myc antisense RNA restricts the differentiation potential of primitive neuroectodermal cell lines;Whitesell;Mol. Cell Biol.,1991

5. Cancer therapeutics: targeting the dark side of Myc;Ponzielli;Eur. J. Cancer,2005

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma;Communications Biology;2024-07-30

2. A multi-omics approach for biomarker discovery in neuroblastoma: a network-based framework;npj Systems Biology and Applications;2024-05-17

3. Comparison of 177Lu-octreotate and 177Lu-octreotide for treatment in human neuroblastoma-bearing mice;Heliyon;2024-05

4. Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification;British Journal of Cancer;2024-03-29

5. Interferon-gamma regulates the progression of neuroblastoma cells through interferon-regulatory factor-1;BIOCELL;2024